Ampio Pharmaceuticals, Inc. (AMPE)
NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.103
+0.000 (0.10%)
At close: Aug 17, 2022 4:00 PM
0.105
+0.002 (1.843%)
Pre-market:
Aug 18, 2022 6:09 AM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization
|
23 | 115 | 294 | 92 | 42 | 309 | 51 | 182 | 178 | 298 | 133 | Upgrade
|
| Market Cap Growth
|
- | -60.84% | 218.13% | 119.53% | -86.37% | 500.47% | -71.72% | 2.09% | -40.17% | 124.26% | 8.02% | Upgrade
|
| Enterprise Value
|
1 | 82 | 278 | 87 | 35 | 301 | 46 | 166 | 128 | 272 | 115 | Upgrade
|
| PE Ratio
|
- | -6.75 | -18.51 | -6.79 | 1.24 | -5.96 | -2.69 | -7.55 | -5.69 | -12.41 | -11.46 | Upgrade
|
| PS Ratio
|
- | - | - | - | - | - | - | - | - | 5959.17 | 2657.30 | Upgrade
|
| PB Ratio
|
1.16 | 4.22 | 16.80 | 14.36 | 8.05 | -9.04 | 7.76 | 4.92 | 2.70 | 9.01 | 5.58 | Upgrade
|
| EV/Sales Ratio
|
- | - | - | - | - | - | - | - | - | 5317.36 | 2251.28 | Upgrade
|
| EV/EBITDA Ratio
|
- | - | - | - | 0.95 | - | - | - | - | - | - | Upgrade
|
| EV/EBIT Ratio
|
- | - | - | - | 0.98 | - | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio
|
0.02 | 0.02 | 0.05 | 0.19 | 0.09 | - | - | - | - | - | - | Upgrade
|
| Debt / EBITDA Ratio
|
-0.03 | -0.04 | -0.06 | -0.10 | 0.01 | - | - | - | - | - | - | Upgrade
|
| Debt / FCF Ratio
|
-0.02 | -0.04 | -0.06 | -0.08 | -0.04 | - | - | - | - | - | - | Upgrade
|
| Current Ratio
|
4.85 | 6.96 | 10.08 | 1.93 | 5.80 | 2.18 | 2.53 | 5.30 | 13.93 | 10.69 | 10.91 | Upgrade
|
| Asset Turnover
|
- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | Upgrade
|
| Return on Equity (ROE)
|
-80.80% | -83.60% | -173.80% | -256.90% | -2638.40% | 810.10% | -161.50% | -49.80% | -40.80% | -85.50% | -58.40% | Upgrade
|
| Return on Assets (ROA)
|
-57.90% | -62.20% | -107.50% | -85.90% | 243.00% | -427.00% | -111.70% | -42.30% | -38.50% | -77.60% | -53.90% | Upgrade
|
| Return on Capital (ROIC)
|
-2567.90% | -528.80% | -343.10% | -223.70% | 754.80% | -1046.80% | -272.20% | -116.70% | -228.00% | -391.00% | -177.60% | Upgrade
|
| Earnings Yield
|
-75.30% | -14.80% | -5.40% | -14.70% | 80.70% | -16.80% | -37.20% | -13.20% | -17.60% | -8.10% | -8.70% | Upgrade
|
| FCF Yield
|
-79.40% | -12.30% | -5.00% | -16.70% | -30.20% | -3.70% | -28.40% | -14.60% | -22.10% | -6.90% | -7.30% | Upgrade
|
| Buyback Yield / Dilution
|
-12.23% | -18.58% | -31.81% | -43.96% | -39.50% | -21.43% | -3.43% | -3.52% | -31.16% | -12.68% | -30.64% | Upgrade
|
| Total Shareholder Return
|
-12.23% | -18.58% | -31.81% | -43.96% | -39.50% | -21.43% | -3.43% | -3.52% | -31.16% | -12.68% | -30.64% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).